

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 8.14408779 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 7.50585602 |
| 3 | definitive hemopoiesis (GO:0060216) | 7.27462442 |
| 4 | lymphangiogenesis (GO:0001946) | 6.81125856 |
| 5 | platelet dense granule organization (GO:0060155) | 6.66763855 |
| 6 | sprouting angiogenesis (GO:0002040) | 6.09725555 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.99946223 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.99946223 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.99167926 |
| 10 | wound healing, spreading of epidermal cells (GO:0035313) | 5.68057698 |
| 11 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 5.59315197 |
| 12 | megakaryocyte development (GO:0035855) | 5.42357554 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.18631197 |
| 14 | endothelium development (GO:0003158) | 4.98130113 |
| 15 | lymphoid progenitor cell differentiation (GO:0002320) | 4.97216624 |
| 16 | viral transcription (GO:0019083) | 4.80853695 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.77947692 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.75346369 |
| 19 | chondrocyte proliferation (GO:0035988) | 4.68574085 |
| 20 | response to interferon-beta (GO:0035456) | 4.65036029 |
| 21 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.63118356 |
| 22 | positive regulation of vasculogenesis (GO:2001214) | 4.62418498 |
| 23 | phospholipid scrambling (GO:0017121) | 4.60290311 |
| 24 | secretory granule organization (GO:0033363) | 4.56070288 |
| 25 | translational termination (GO:0006415) | 4.53835999 |
| 26 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 4.51029357 |
| 27 | negative regulation of endothelial cell migration (GO:0010596) | 4.49928988 |
| 28 | endothelial cell morphogenesis (GO:0001886) | 4.49647808 |
| 29 | angiogenesis involved in wound healing (GO:0060055) | 4.35193764 |
| 30 | Notch signaling involved in heart development (GO:0061314) | 4.34557892 |
| 31 | patterning of blood vessels (GO:0001569) | 4.25860024 |
| 32 | blood vessel maturation (GO:0001955) | 4.24217880 |
| 33 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.20699175 |
| 34 | renal filtration (GO:0097205) | 4.15127570 |
| 35 | cell migration involved in sprouting angiogenesis (GO:0002042) | 4.13891711 |
| 36 | endothelial cell proliferation (GO:0001935) | 4.13429992 |
| 37 | basement membrane organization (GO:0071711) | 4.10145802 |
| 38 | substrate-dependent cell migration (GO:0006929) | 4.07804203 |
| 39 | cell adhesion mediated by integrin (GO:0033627) | 4.06676951 |
| 40 | endothelial cell differentiation (GO:0045446) | 4.05148860 |
| 41 | regulation of blood vessel endothelial cell migration (GO:0043535) | 4.03500411 |
| 42 | response to interferon-alpha (GO:0035455) | 4.03441179 |
| 43 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.98991450 |
| 44 | translational elongation (GO:0006414) | 3.95176407 |
| 45 | regulation of endothelial cell differentiation (GO:0045601) | 3.94799540 |
| 46 | mature B cell differentiation involved in immune response (GO:0002313) | 3.92539762 |
| 47 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.92139335 |
| 48 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.92139335 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.91656572 |
| 50 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.90158194 |
| 51 | artery development (GO:0060840) | 3.88233151 |
| 52 | embryonic hemopoiesis (GO:0035162) | 3.79958171 |
| 53 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.79924203 |
| 54 | cotranslational protein targeting to membrane (GO:0006613) | 3.79403588 |
| 55 | protein targeting to ER (GO:0045047) | 3.77170674 |
| 56 | L-fucose catabolic process (GO:0042355) | 3.76238929 |
| 57 | fucose catabolic process (GO:0019317) | 3.76238929 |
| 58 | L-fucose metabolic process (GO:0042354) | 3.76238929 |
| 59 | endosome to melanosome transport (GO:0035646) | 3.75845753 |
| 60 | endosome to pigment granule transport (GO:0043485) | 3.75845753 |
| 61 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72245747 |
| 62 | negative regulation of focal adhesion assembly (GO:0051895) | 3.68705844 |
| 63 | negative regulation of cell junction assembly (GO:1901889) | 3.68705844 |
| 64 | negative regulation of adherens junction organization (GO:1903392) | 3.68705844 |
| 65 | lymph vessel development (GO:0001945) | 3.64440670 |
| 66 | positive regulation of urine volume (GO:0035810) | 3.63334621 |
| 67 | wound healing, spreading of cells (GO:0044319) | 3.61221218 |
| 68 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.60583319 |
| 69 | protein localization to endoplasmic reticulum (GO:0070972) | 3.59650116 |
| 70 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.58883588 |
| 71 | regulation of endothelial cell migration (GO:0010594) | 3.58800281 |
| 72 | endodermal cell differentiation (GO:0035987) | 3.56274855 |
| 73 | ribosomal small subunit biogenesis (GO:0042274) | 3.56213852 |
| 74 | angiogenesis (GO:0001525) | 3.55820400 |
| 75 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.54591656 |
| 76 | DNA deamination (GO:0045006) | 3.52520950 |
| 77 | response to protozoan (GO:0001562) | 3.51757880 |
| 78 | defense response to protozoan (GO:0042832) | 3.50563885 |
| 79 | viral life cycle (GO:0019058) | 3.47304538 |
| 80 | blood vessel endothelial cell migration (GO:0043534) | 3.47136382 |
| 81 | necroptotic process (GO:0070266) | 3.45996481 |
| 82 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.43950072 |
| 83 | lymph node development (GO:0048535) | 3.39488995 |
| 84 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.39077766 |
| 85 | positive regulation of endothelial cell migration (GO:0010595) | 3.38746214 |
| 86 | trabecula morphogenesis (GO:0061383) | 3.38090563 |
| 87 | heart trabecula formation (GO:0060347) | 3.37751642 |
| 88 | heart trabecula morphogenesis (GO:0061384) | 3.37213985 |
| 89 | negative regulation of epithelial cell migration (GO:0010633) | 3.36902511 |
| 90 | positive regulation of odontogenesis (GO:0042482) | 3.35432776 |
| 91 | positive regulation of receptor recycling (GO:0001921) | 3.35264220 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.34571291 |
| 93 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.32855510 |
| 94 | maturation of SSU-rRNA (GO:0030490) | 3.31320797 |
| 95 | hyaluronan catabolic process (GO:0030214) | 3.30262672 |
| 96 | regulation of vasculogenesis (GO:2001212) | 3.28311078 |
| 97 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.27212815 |
| 98 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.26558279 |
| 99 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.26360963 |
| 100 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.25318146 |
| 101 | axon extension involved in axon guidance (GO:0048846) | 3.25318146 |
| 102 | T cell homeostasis (GO:0043029) | 3.23322991 |
| 103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.19565793 |
| 104 | mast cell activation (GO:0045576) | 3.17161141 |
| 105 | cellular protein complex disassembly (GO:0043624) | 3.16039873 |
| 106 | vasculogenesis (GO:0001570) | 3.15796002 |
| 107 | purine-containing compound salvage (GO:0043101) | 3.14892212 |
| 108 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.14117718 |
| 109 | response to type I interferon (GO:0034340) | 3.13358149 |
| 110 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.12358205 |
| 111 | positive regulation of cell junction assembly (GO:1901890) | 3.12203130 |
| 112 | positive regulation of focal adhesion assembly (GO:0051894) | 3.12203130 |
| 113 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.10940228 |
| 114 | Peyers patch development (GO:0048541) | 3.10940228 |
| 115 | cellular response to type I interferon (GO:0071357) | 3.08245370 |
| 116 | type I interferon signaling pathway (GO:0060337) | 3.08245370 |
| 117 | negative regulation of angiogenesis (GO:0016525) | 3.07614256 |
| 118 | regulation of B cell differentiation (GO:0045577) | 3.04944249 |
| 119 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.03998214 |
| 120 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.02682081 |
| 121 | endothelial tube morphogenesis (GO:0061154) | 3.01288254 |
| 122 | morphogenesis of an endothelium (GO:0003159) | 3.01288254 |
| 123 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.00954935 |
| 124 | positive regulation of respiratory burst (GO:0060267) | 3.00821233 |
| 125 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.00286823 |
| 126 | regulation of endothelial cell apoptotic process (GO:2000351) | 3.00266471 |
| 127 | histamine transport (GO:0051608) | 2.98186178 |
| 128 | positive regulation of adherens junction organization (GO:1903393) | 2.97060537 |
| 129 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.95803610 |
| 130 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.95415531 |
| 131 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95037552 |
| 132 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.93481484 |
| 133 | regulation of erythrocyte differentiation (GO:0045646) | 2.93264612 |
| 134 | negative regulation of viral entry into host cell (GO:0046597) | 2.92971323 |
| 135 | mast cell degranulation (GO:0043303) | 2.92791424 |
| 136 | mast cell activation involved in immune response (GO:0002279) | 2.92791424 |
| 137 | regulation of necroptotic process (GO:0060544) | 2.92482464 |
| 138 | blood vessel remodeling (GO:0001974) | 2.90751064 |
| 139 | translational initiation (GO:0006413) | 2.90691803 |
| 140 | negative regulation of anoikis (GO:2000811) | 2.90518282 |
| 141 | regulation of epithelial cell migration (GO:0010632) | 2.89354058 |
| 142 | hematopoietic stem cell proliferation (GO:0071425) | 2.88067051 |
| 143 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.87140086 |
| 144 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.86059913 |
| 145 | leukocyte homeostasis (GO:0001776) | 2.85888189 |
| 146 | negative regulation of stress fiber assembly (GO:0051497) | 2.85884597 |
| 147 | positive regulation of epithelial cell migration (GO:0010634) | 2.85624950 |
| 148 | ganglion development (GO:0061548) | 2.85369789 |
| 149 | regulation of focal adhesion assembly (GO:0051893) | 2.85151454 |
| 150 | regulation of cell-substrate junction assembly (GO:0090109) | 2.85151454 |
| 151 | mature B cell differentiation (GO:0002335) | 2.85040271 |
| 152 | endothelial cell migration (GO:0043542) | 2.85039023 |
| 153 | cytokine production involved in immune response (GO:0002367) | 2.82824881 |
| 154 | protein complex disassembly (GO:0043241) | 2.82368370 |
| 155 | IMP metabolic process (GO:0046040) | 2.82153436 |
| 156 | negative regulation of vasculature development (GO:1901343) | 2.82153126 |
| 157 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.81800722 |
| 158 | negative regulation of platelet activation (GO:0010544) | 2.81118684 |
| 159 | polyketide metabolic process (GO:0030638) | 2.81037332 |
| 160 | doxorubicin metabolic process (GO:0044598) | 2.81037332 |
| 161 | daunorubicin metabolic process (GO:0044597) | 2.81037332 |
| 162 | regulation of natural killer cell differentiation (GO:0032823) | 2.79442296 |
| 163 | programmed necrotic cell death (GO:0097300) | 2.79348062 |
| 164 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.79077443 |
| 165 | regulation of adherens junction organization (GO:1903391) | 2.78106654 |
| 166 | protein localization to endosome (GO:0036010) | 2.78045997 |
| 167 | negative regulation of protein autophosphorylation (GO:0031953) | 2.76863620 |
| 168 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.76113017 |
| 169 | surfactant homeostasis (GO:0043129) | 2.75829444 |
| 170 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.75821736 |
| 171 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.74949157 |
| 172 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.73276842 |
| 173 | glomerular filtration (GO:0003094) | 2.73260497 |
| 174 | macrophage differentiation (GO:0030225) | 2.73247902 |
| 175 | nephron epithelium development (GO:0072009) | 2.72746791 |
| 176 | negative regulation of cell-substrate adhesion (GO:0010812) | 2.71606349 |
| 177 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.71027432 |
| 178 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.70933331 |
| 179 | cell migration involved in heart development (GO:0060973) | 2.70549288 |
| 180 | positive regulation of lipid kinase activity (GO:0090218) | 2.70094237 |
| 181 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.70062565 |
| 182 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.68430451 |
| 183 | embryonic heart tube development (GO:0035050) | 2.66634592 |
| 184 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.65529418 |
| 185 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.63521749 |
| 186 | heparin biosynthetic process (GO:0030210) | 2.62695590 |
| 187 | heparin metabolic process (GO:0030202) | 2.62695590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.71917428 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.30716235 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.35230974 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.11110074 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.78703725 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.73307172 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.71028514 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.64174370 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.48232096 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.22186194 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.21897782 |
| 12 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.95319169 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.93295619 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89773273 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.89133228 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.86221259 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81666939 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.76569527 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.72162327 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.71338963 |
| 21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.68656075 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64957383 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.60379911 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.59166681 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.55800864 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.53276451 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.44053945 |
| 28 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.43633323 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.39477425 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.39401075 |
| 31 | CJUN_26792858_Chip-Seq_BT549_Human | 2.35770795 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.27599199 |
| 33 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.24851708 |
| 34 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.22869855 |
| 35 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.19876598 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.18954634 |
| 37 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.13317793 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.11885748 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11787161 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.11535389 |
| 41 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.09410635 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.06345082 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03783170 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.03630939 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03170611 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.00397956 |
| 47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99608543 |
| 48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95821614 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.88608700 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88140760 |
| 51 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.85511794 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.85511794 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84360603 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84341317 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.83042883 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82871761 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82074184 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.80224449 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79561369 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.79541234 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.78918641 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78641996 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74352751 |
| 64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.72269837 |
| 65 | MYB_26560356_Chip-Seq_TH2_Human | 1.71936520 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71155095 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.70726112 |
| 68 | MAF_26560356_Chip-Seq_TH1_Human | 1.68215236 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.67877552 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.67877552 |
| 71 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67767542 |
| 72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.67046063 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66686826 |
| 74 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.64719960 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.62684015 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.61658138 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.59066714 |
| 78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.58238860 |
| 79 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.57534044 |
| 80 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.54154178 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54087146 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53610761 |
| 83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53329336 |
| 84 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.52722481 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52300856 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47077257 |
| 87 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46334254 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45529262 |
| 89 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.41839396 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38761940 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37796337 |
| 92 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37305288 |
| 93 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.36794252 |
| 94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.33883567 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33807604 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33021257 |
| 97 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.32927574 |
| 98 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32711864 |
| 99 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.32634066 |
| 100 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.32634066 |
| 101 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.31952809 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31705119 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30435419 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30435419 |
| 105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29854690 |
| 106 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.28752472 |
| 107 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.27384311 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26794692 |
| 109 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26769159 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.26327442 |
| 111 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23169695 |
| 112 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.22254581 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20516934 |
| 114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20243194 |
| 115 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19199254 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.18344645 |
| 117 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.18022364 |
| 118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.17612399 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17292989 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17176391 |
| 121 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16847648 |
| 122 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.15628165 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.15476585 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15086339 |
| 125 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12726044 |
| 126 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12156399 |
| 127 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12127603 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10140238 |
| 129 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10023580 |
| 130 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07832451 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05556341 |
| 132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04235926 |
| 133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04181656 |
| 134 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04176757 |
| 135 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03686557 |
| 136 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03497746 |
| 137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03306942 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03208648 |
| 139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02369435 |
| 140 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01543972 |
| 141 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01356604 |
| 142 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01044493 |
| 143 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00907057 |
| 144 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.00645030 |
| 145 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00203926 |
| 146 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.99309803 |
| 147 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98995713 |
| 148 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98905948 |
| 149 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98478903 |
| 150 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98216912 |
| 151 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.98024021 |
| 152 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97496077 |
| 153 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.97406901 |
| 154 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.97077436 |
| 155 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96141301 |
| 156 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95629092 |
| 157 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95395165 |
| 158 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.95148511 |
| 159 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94148702 |
| 160 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94059587 |
| 161 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.92686344 |
| 162 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92623659 |
| 163 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92445861 |
| 164 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91897660 |
| 165 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91610013 |
| 166 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91440555 |
| 167 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91074594 |
| 168 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91009291 |
| 169 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90898948 |
| 170 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90564852 |
| 171 | MAF_26560356_Chip-Seq_TH2_Human | 0.90400782 |
| 172 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90332915 |
| 173 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.90048726 |
| 174 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89907915 |
| 175 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89073731 |
| 176 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.88930020 |
| 177 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88750545 |
| 178 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88696582 |
| 179 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.88621611 |
| 180 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88586068 |
| 181 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87533362 |
| 182 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87397089 |
| 183 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85751905 |
| 184 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84345295 |
| 185 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.83424274 |
| 186 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83300471 |
| 187 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82554158 |
| 188 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81952820 |
| 189 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81184694 |
| 190 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79729007 |
| 191 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.79042962 |
| 192 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79012733 |
| 193 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.78799888 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 5.09345848 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.20889096 |
| 3 | MP0004147_increased_porphyrin_level | 3.78622725 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.64116484 |
| 5 | MP0001879_abnormal_lymphatic_vessel | 3.45432321 |
| 6 | MP0003724_increased_susceptibility_to | 3.41426797 |
| 7 | MP0004808_abnormal_hematopoietic_stem | 3.15314340 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.92450828 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.92450828 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.85312768 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 2.66475535 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.59663319 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.59318757 |
| 14 | MP0009785_altered_susceptibility_to | 2.57305093 |
| 15 | MP0009379_abnormal_foot_pigmentation | 2.52188185 |
| 16 | MP0009278_abnormal_bone_marrow | 2.49956842 |
| 17 | MP0005623_abnormal_meninges_morphology | 2.49136065 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.42799768 |
| 19 | MP0006054_spinal_hemorrhage | 2.42315096 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 2.41355427 |
| 21 | MP0005174_abnormal_tail_pigmentation | 2.34482135 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.16203398 |
| 23 | MP0003828_pulmonary_edema | 2.07718487 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 1.98169227 |
| 25 | MP0001873_stomach_inflammation | 1.94124675 |
| 26 | MP0005275_abnormal_skin_tensile | 1.89938859 |
| 27 | MP0005670_abnormal_white_adipose | 1.88478349 |
| 28 | MP0001853_heart_inflammation | 1.86011315 |
| 29 | MP0009697_abnormal_copulation | 1.85628436 |
| 30 | MP0005671_abnormal_response_to | 1.80788019 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.77429853 |
| 32 | MP0005025_abnormal_response_to | 1.77183737 |
| 33 | MP0002295_abnormal_pulmonary_circulatio | 1.74342818 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.70361021 |
| 35 | MP0001188_hyperpigmentation | 1.66850250 |
| 36 | MP0000685_abnormal_immune_system | 1.65569616 |
| 37 | MP0002095_abnormal_skin_pigmentation | 1.64138567 |
| 38 | MP0002398_abnormal_bone_marrow | 1.62360276 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.61005176 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.58134678 |
| 41 | MP0000343_altered_response_to | 1.54889516 |
| 42 | MP0001614_abnormal_blood_vessel | 1.53542730 |
| 43 | MP0003091_abnormal_cell_migration | 1.52145627 |
| 44 | MP0003943_abnormal_hepatobiliary_system | 1.50034528 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.49827659 |
| 46 | MP0003303_peritoneal_inflammation | 1.48237707 |
| 47 | MP0000751_myopathy | 1.46954182 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.46090038 |
| 49 | MP0002933_joint_inflammation | 1.45210054 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.44311776 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.43958701 |
| 52 | MP0002723_abnormal_immune_serum | 1.43929687 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.43235554 |
| 54 | MP0001819_abnormal_immune_cell | 1.42382761 |
| 55 | MP0001800_abnormal_humoral_immune | 1.40124674 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.39623979 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.39487957 |
| 58 | MP0005409_darkened_coat_color | 1.38448433 |
| 59 | MP0002925_abnormal_cardiovascular_devel | 1.36637418 |
| 60 | MP0002722_abnormal_immune_system | 1.35792149 |
| 61 | MP0002419_abnormal_innate_immunity | 1.33699145 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.32794210 |
| 63 | MP0002429_abnormal_blood_cell | 1.30701253 |
| 64 | MP0000716_abnormal_immune_system | 1.30681295 |
| 65 | MP0002127_abnormal_cardiovascular_syste | 1.30255796 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.29916930 |
| 67 | MP0000490_abnormal_crypts_of | 1.25133205 |
| 68 | MP0003866_abnormal_defecation | 1.24600408 |
| 69 | MP0001958_emphysema | 1.24439419 |
| 70 | MP0010030_abnormal_orbit_morphology | 1.23381512 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.21168539 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.21130521 |
| 73 | MP0005503_abnormal_tendon_morphology | 1.17983245 |
| 74 | MP0005000_abnormal_immune_tolerance | 1.17627613 |
| 75 | MP0002006_tumorigenesis | 1.16731641 |
| 76 | MP0008007_abnormal_cellular_replicative | 1.16083035 |
| 77 | MP0000749_muscle_degeneration | 1.14954381 |
| 78 | MP0005023_abnormal_wound_healing | 1.12501697 |
| 79 | MP0008469_abnormal_protein_level | 1.11907300 |
| 80 | MP0005375_adipose_tissue_phenotype | 1.08024862 |
| 81 | MP0002972_abnormal_cardiac_muscle | 1.05535172 |
| 82 | MP0000249_abnormal_blood_vessel | 1.04120509 |
| 83 | MP0003279_aneurysm | 1.03524188 |
| 84 | MP0004233_abnormal_muscle_weight | 1.00449232 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.99819489 |
| 86 | MP0002405_respiratory_system_inflammati | 0.98943536 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.98735698 |
| 88 | MP0003436_decreased_susceptibility_to | 0.98343796 |
| 89 | MP0005620_abnormal_muscle_contractility | 0.98178263 |
| 90 | MP0001845_abnormal_inflammatory_respons | 0.97423760 |
| 91 | MP0004272_abnormal_basement_membrane | 0.94411413 |
| 92 | MP0001849_ear_inflammation | 0.93348601 |
| 93 | MP0005330_cardiomyopathy | 0.93035944 |
| 94 | MP0005387_immune_system_phenotype | 0.92363042 |
| 95 | MP0001790_abnormal_immune_system | 0.92363042 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.91027829 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.90385162 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89299526 |
| 99 | MP0003186_abnormal_redox_activity | 0.89189891 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.89164985 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.88983324 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.88889547 |
| 103 | MP0002168_other_aberrant_phenotype | 0.87810593 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.87536930 |
| 105 | MP0002108_abnormal_muscle_morphology | 0.87106812 |
| 106 | MP0005165_increased_susceptibility_to | 0.86150202 |
| 107 | MP0004484_altered_response_of | 0.86011136 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.85825879 |
| 109 | MP0001784_abnormal_fluid_regulation | 0.85188988 |
| 110 | MP0004130_abnormal_muscle_cell | 0.84733055 |
| 111 | MP0002128_abnormal_blood_circulation | 0.84438224 |
| 112 | MP0003941_abnormal_skin_development | 0.83938172 |
| 113 | MP0004145_abnormal_muscle_electrophysio | 0.83889197 |
| 114 | MP0000266_abnormal_heart_morphology | 0.83253911 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.83190720 |
| 116 | MP0009764_decreased_sensitivity_to | 0.80986980 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.80345855 |
| 118 | MP0003868_abnormal_feces_composition | 0.80082056 |
| 119 | MP0004087_abnormal_muscle_fiber | 0.78426512 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.78406333 |
| 121 | MP0004036_abnormal_muscle_relaxation | 0.78023006 |
| 122 | MP0004085_abnormal_heartbeat | 0.77795461 |
| 123 | MP0000733_abnormal_muscle_development | 0.77720534 |
| 124 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76572588 |
| 125 | MP0002019_abnormal_tumor_incidence | 0.75419583 |
| 126 | MP0005164_abnormal_response_to | 0.75171768 |
| 127 | MP0009763_increased_sensitivity_to | 0.74717556 |
| 128 | MP0005388_respiratory_system_phenotype | 0.74638873 |
| 129 | MP0002133_abnormal_respiratory_system | 0.74638873 |
| 130 | MP0001764_abnormal_homeostasis | 0.74161609 |
| 131 | MP0010630_abnormal_cardiac_muscle | 0.72960681 |
| 132 | MP0004510_myositis | 0.72932941 |
| 133 | MP0003448_altered_tumor_morphology | 0.72383574 |
| 134 | MP0001986_abnormal_taste_sensitivity | 0.72040957 |
| 135 | MP0009333_abnormal_splenocyte_physiolog | 0.71927676 |
| 136 | MP0005385_cardiovascular_system_phenoty | 0.71382133 |
| 137 | MP0001544_abnormal_cardiovascular_syste | 0.71382133 |
| 138 | MP0005257_abnormal_intraocular_pressure | 0.70988680 |
| 139 | MP0000598_abnormal_liver_morphology | 0.70720662 |
| 140 | MP0000759_abnormal_skeletal_muscle | 0.69436294 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.69177484 |
| 142 | MP0009053_abnormal_anal_canal | 0.68813962 |
| 143 | MP0000015_abnormal_ear_pigmentation | 0.68723332 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.68176877 |
| 145 | MP0003984_embryonic_growth_retardation | 0.67628624 |
| 146 | MP0001915_intracranial_hemorrhage | 0.67472367 |
| 147 | MP0002332_abnormal_exercise_endurance | 0.67233438 |
| 148 | MP0006138_congestive_heart_failure | 0.67219566 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66610114 |
| 150 | MP0001663_abnormal_digestive_system | 0.65803160 |
| 151 | MP0002088_abnormal_embryonic_growth/wei | 0.65240669 |
| 152 | MP0000467_abnormal_esophagus_morphology | 0.64666044 |
| 153 | MP0003385_abnormal_body_wall | 0.64651362 |
| 154 | MP0005508_abnormal_skeleton_morphology | 0.64301302 |
| 155 | MP0004215_abnormal_myocardial_fiber | 0.64291403 |
| 156 | MP0002086_abnormal_extraembryonic_tissu | 0.63614900 |
| 157 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63142811 |
| 158 | MP0003935_abnormal_craniofacial_develop | 0.60685092 |
| 159 | MP0005187_abnormal_penis_morphology | 0.59184746 |
| 160 | MP0003045_fibrosis | 0.58917728 |
| 161 | MP0009384_cardiac_valve_regurgitation | 0.57997521 |
| 162 | MP0005197_abnormal_uvea_morphology | 0.55507274 |
| 163 | MP0002106_abnormal_muscle_physiology | 0.52584544 |
| 164 | MP0002971_abnormal_brown_adipose | 0.52529386 |
| 165 | MP0000049_abnormal_middle_ear | 0.52469198 |
| 166 | MP0005369_muscle_phenotype | 0.52265560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.40692448 |
| 2 | Thrombocytosis (HP:0001894) | 5.82976458 |
| 3 | Arterial tortuosity (HP:0005116) | 5.31299263 |
| 4 | Vascular tortuosity (HP:0004948) | 5.11509052 |
| 5 | Premature rupture of membranes (HP:0001788) | 4.87706920 |
| 6 | Prolonged bleeding time (HP:0003010) | 4.84422630 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 4.73068451 |
| 8 | Aplastic anemia (HP:0001915) | 4.55395041 |
| 9 | Cerebral aneurysm (HP:0004944) | 4.55121672 |
| 10 | Chronic otitis media (HP:0000389) | 4.45663330 |
| 11 | Esophageal varix (HP:0002040) | 4.31462622 |
| 12 | IgM deficiency (HP:0002850) | 4.31182519 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.21830661 |
| 14 | Aortic dissection (HP:0002647) | 4.20415094 |
| 15 | Aortic aneurysm (HP:0004942) | 4.14378424 |
| 16 | Abnormal number of erythroid precursors (HP:0012131) | 4.13768916 |
| 17 | Wrist flexion contracture (HP:0001239) | 4.04755910 |
| 18 | Abnormal platelet function (HP:0011869) | 3.90916037 |
| 19 | Impaired platelet aggregation (HP:0003540) | 3.90916037 |
| 20 | Spinal rigidity (HP:0003306) | 3.87661836 |
| 21 | Cerebral hemorrhage (HP:0001342) | 3.83379662 |
| 22 | Tetraparesis (HP:0002273) | 3.81488929 |
| 23 | Acute myeloid leukemia (HP:0004808) | 3.76089762 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.72772896 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.65152282 |
| 26 | Petechiae (HP:0000967) | 3.59878015 |
| 27 | Myositis (HP:0100614) | 3.57775795 |
| 28 | Conjunctival telangiectasia (HP:0000524) | 3.53996332 |
| 29 | Epistaxis (HP:0000421) | 3.52718288 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.41338205 |
| 31 | Myocardial infarction (HP:0001658) | 3.37481142 |
| 32 | Acute lymphatic leukemia (HP:0006721) | 3.35749782 |
| 33 | Reticulocytopenia (HP:0001896) | 3.34514977 |
| 34 | Reduced antithrombin III activity (HP:0001976) | 3.32272570 |
| 35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.32255138 |
| 36 | Nasal polyposis (HP:0100582) | 3.28228146 |
| 37 | Adactyly (HP:0009776) | 3.22319363 |
| 38 | Skull defect (HP:0001362) | 3.21125662 |
| 39 | Cervical subluxation (HP:0003308) | 3.14171261 |
| 40 | Microcytic anemia (HP:0001935) | 3.13223066 |
| 41 | Overgrowth (HP:0001548) | 3.13053966 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.95924880 |
| 43 | Hematochezia (HP:0002573) | 2.95856540 |
| 44 | Lymphangioma (HP:0100764) | 2.90939361 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.90363172 |
| 46 | Broad metatarsal (HP:0001783) | 2.90071317 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 2.89251738 |
| 48 | Increased connective tissue (HP:0009025) | 2.89222021 |
| 49 | Type 2 muscle fiber atrophy (HP:0003554) | 2.87134298 |
| 50 | Polycythemia (HP:0001901) | 2.84371607 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.84151018 |
| 52 | Hyporeflexia of lower limbs (HP:0002600) | 2.83926924 |
| 53 | Muscle fiber splitting (HP:0003555) | 2.78780871 |
| 54 | Muscle fiber atrophy (HP:0100295) | 2.78323031 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.77773535 |
| 56 | Nonprogressive disorder (HP:0003680) | 2.77728972 |
| 57 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.74873414 |
| 58 | Hypoplasia of the iris (HP:0007676) | 2.72892909 |
| 59 | Soft skin (HP:0000977) | 2.67418752 |
| 60 | Nuclear cataract (HP:0100018) | 2.64355256 |
| 61 | Wormian bones (HP:0002645) | 2.63785038 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.60728176 |
| 63 | Aortic valve stenosis (HP:0001650) | 2.60214850 |
| 64 | Porencephaly (HP:0002132) | 2.59025628 |
| 65 | Stenosis of the external auditory canal (HP:0000402) | 2.57419295 |
| 66 | Mitral valve prolapse (HP:0001634) | 2.56650521 |
| 67 | Visceral angiomatosis (HP:0100761) | 2.55400817 |
| 68 | Hemangiomatosis (HP:0007461) | 2.47382103 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 2.47110375 |
| 70 | Aneurysm (HP:0002617) | 2.46429106 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46232951 |
| 72 | Purpura (HP:0000979) | 2.45649345 |
| 73 | Shallow orbits (HP:0000586) | 2.43287665 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.40711882 |
| 75 | Ectopia lentis (HP:0001083) | 2.38882616 |
| 76 | Amaurosis fugax (HP:0100576) | 2.36722235 |
| 77 | Myotonia (HP:0002486) | 2.35938311 |
| 78 | Growth hormone excess (HP:0000845) | 2.33833953 |
| 79 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.32378525 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.32011644 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.31341884 |
| 82 | Menorrhagia (HP:0000132) | 2.30738340 |
| 83 | Myelodysplasia (HP:0002863) | 2.29302778 |
| 84 | Absent hand (HP:0004050) | 2.29135474 |
| 85 | Pallor (HP:0000980) | 2.28561185 |
| 86 | Panhypogammaglobulinemia (HP:0003139) | 2.27888006 |
| 87 | Difficulty running (HP:0009046) | 2.26494244 |
| 88 | Blue sclerae (HP:0000592) | 2.26149250 |
| 89 | Large hands (HP:0001176) | 2.26096793 |
| 90 | Striae distensae (HP:0001065) | 2.26054129 |
| 91 | Gingival bleeding (HP:0000225) | 2.26017964 |
| 92 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.25636660 |
| 93 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.25636660 |
| 94 | Abnormal protein glycosylation (HP:0012346) | 2.25636660 |
| 95 | Abnormal glycosylation (HP:0012345) | 2.25636660 |
| 96 | Dilatation of the ascending aorta (HP:0005111) | 2.25219623 |
| 97 | Hip contracture (HP:0003273) | 2.24672212 |
| 98 | Nonimmune hydrops fetalis (HP:0001790) | 2.23027984 |
| 99 | Limited hip movement (HP:0008800) | 2.22379841 |
| 100 | Hyperlipoproteinemia (HP:0010980) | 2.20815593 |
| 101 | Nemaline bodies (HP:0003798) | 2.20366504 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.19849973 |
| 103 | Venous insufficiency (HP:0005293) | 2.18530160 |
| 104 | Weak cry (HP:0001612) | 2.18013117 |
| 105 | Pancytopenia (HP:0001876) | 2.16667277 |
| 106 | Congenital, generalized hypertrichosis (HP:0004540) | 2.13624863 |
| 107 | Colitis (HP:0002583) | 2.13517877 |
| 108 | Vertebral compression fractures (HP:0002953) | 2.13059760 |
| 109 | Cellulitis (HP:0100658) | 2.12615480 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.11237976 |
| 111 | Coxa vara (HP:0002812) | 2.10868524 |
| 112 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.10525950 |
| 113 | Erythema (HP:0010783) | 2.09788764 |
| 114 | Pulmonary hypertension (HP:0002092) | 2.08743189 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 2.08629437 |
| 116 | Bladder diverticulum (HP:0000015) | 2.07721539 |
| 117 | Arterial thrombosis (HP:0004420) | 2.06376386 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.06354879 |
| 119 | Orchitis (HP:0100796) | 2.06229873 |
| 120 | Portal hypertension (HP:0001409) | 2.06045637 |
| 121 | Chest pain (HP:0100749) | 2.06022632 |
| 122 | Stroke (HP:0001297) | 2.04313878 |
| 123 | Acanthosis nigricans (HP:0000956) | 2.03399892 |
| 124 | Joint contractures involving the joints of the feet (HP:0100492) | 2.02695810 |
| 125 | Flexion contracture of toe (HP:0005830) | 2.02695810 |
| 126 | Distal lower limb muscle weakness (HP:0009053) | 2.02600624 |
| 127 | Ankle contracture (HP:0006466) | 2.02155677 |
| 128 | Muscle fiber inclusion bodies (HP:0100299) | 2.02090819 |
| 129 | Albinism (HP:0001022) | 2.02058701 |
| 130 | Venous abnormality (HP:0002624) | 2.01912388 |
| 131 | Abnormality of the acetabulum (HP:0003170) | 2.01143537 |
| 132 | Progressive muscle weakness (HP:0003323) | 2.00167315 |
| 133 | Esophageal neoplasm (HP:0100751) | 1.99009544 |
| 134 | Neoplasm of head and neck (HP:0012288) | 1.99009544 |
| 135 | Thrombophlebitis (HP:0004418) | 1.98908849 |
| 136 | Macrocytic anemia (HP:0001972) | 1.98156490 |
| 137 | Hypoproteinemia (HP:0003075) | 1.98012972 |
| 138 | Asymmetric septal hypertrophy (HP:0001670) | 1.96556268 |
| 139 | Follicular hyperkeratosis (HP:0007502) | 1.95584270 |
| 140 | Joint stiffness (HP:0001387) | 1.94953779 |
| 141 | Difficulty climbing stairs (HP:0003551) | 1.94448212 |
| 142 | Hemiplegia (HP:0002301) | 1.94195892 |
| 143 | Abnormal platelet volume (HP:0011876) | 1.93941538 |
| 144 | Abnormality of the fingertips (HP:0001211) | 1.93835710 |
| 145 | Lipoatrophy (HP:0100578) | 1.93423240 |
| 146 | Capillary hemangiomas (HP:0005306) | 1.92219232 |
| 147 | Recurrent viral infections (HP:0004429) | 1.92108455 |
| 148 | Abnormality of the columella (HP:0009929) | 1.91844303 |
| 149 | Asplenia (HP:0001746) | 1.91009278 |
| 150 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.90702390 |
| 151 | Cavernous hemangioma (HP:0001048) | 1.90144235 |
| 152 | B lymphocytopenia (HP:0010976) | 1.89671443 |
| 153 | Abnormality of B cell number (HP:0010975) | 1.89671443 |
| 154 | Abnormality of T cells (HP:0002843) | 1.89132256 |
| 155 | Hepatic necrosis (HP:0002605) | 1.88570429 |
| 156 | Abnormality of the hepatic vasculature (HP:0006707) | 1.88556355 |
| 157 | IgG deficiency (HP:0004315) | 1.88411473 |
| 158 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88076769 |
| 159 | Mucosal telangiectasiae (HP:0100579) | 1.86643403 |
| 160 | Camptodactyly of toe (HP:0001836) | 1.86574134 |
| 161 | Patchy hypopigmentation of hair (HP:0011365) | 1.85988755 |
| 162 | Mitral stenosis (HP:0001718) | 1.85728460 |
| 163 | Hyperpituitarism (HP:0010514) | 1.85211860 |
| 164 | Chronic sinusitis (HP:0011109) | 1.84632537 |
| 165 | Pulmonary embolism (HP:0002204) | 1.84023413 |
| 166 | Bruising susceptibility (HP:0000978) | 1.83677941 |
| 167 | Joint laxity (HP:0001388) | 1.83333317 |
| 168 | Disproportionate tall stature (HP:0001519) | 1.82788457 |
| 169 | Abnormality of dentin (HP:0010299) | 1.82495388 |
| 170 | Increased IgE level (HP:0003212) | 1.81354178 |
| 171 | Osteolytic defects of the hand bones (HP:0009699) | 1.80713584 |
| 172 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80713584 |
| 173 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.80486483 |
| 174 | Polygenic inheritance (HP:0010982) | 1.80405618 |
| 175 | Beaking of vertebral bodies (HP:0004568) | 1.80172176 |
| 176 | Vascular calcification (HP:0004934) | 1.79901857 |
| 177 | Vertebral clefting (HP:0008428) | 1.79282574 |
| 178 | Lymphopenia (HP:0001888) | 1.78755708 |
| 179 | Round ear (HP:0100830) | 1.78240137 |
| 180 | Pulmonary artery stenosis (HP:0004415) | 1.77799116 |
| 181 | Facial diplegia (HP:0001349) | 1.77618957 |
| 182 | Fatigue (HP:0012378) | 1.76695234 |
| 183 | Atrioventricular block (HP:0001678) | 1.76041481 |
| 184 | Agammaglobulinemia (HP:0004432) | 1.75091380 |
| 185 | Hepatocellular necrosis (HP:0001404) | 1.75007283 |
| 186 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74534480 |
| 187 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.73675747 |
| 188 | Hypothermia (HP:0002045) | 1.72284392 |
| 189 | Migraine (HP:0002076) | 1.72031981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.52334257 |
| 2 | KIT | 4.25719751 |
| 3 | FLT3 | 4.19898958 |
| 4 | KDR | 3.77582332 |
| 5 | TGFBR1 | 3.51736492 |
| 6 | EPHB2 | 3.13544503 |
| 7 | INSRR | 2.77992345 |
| 8 | TGFBR2 | 2.63875447 |
| 9 | FER | 2.46435253 |
| 10 | TNIK | 2.39800583 |
| 11 | TEC | 2.38539375 |
| 12 | MAP4K1 | 2.32443979 |
| 13 | CSF1R | 2.15673073 |
| 14 | MAP2K3 | 2.14533052 |
| 15 | MATK | 2.05858464 |
| 16 | BTK | 1.95798681 |
| 17 | MUSK | 1.93234188 |
| 18 | STK16 | 1.90570445 |
| 19 | MAP3K12 | 1.82106950 |
| 20 | PTK2 | 1.78830733 |
| 21 | EEF2K | 1.75337979 |
| 22 | NME2 | 1.69028670 |
| 23 | ACVR1B | 1.67476351 |
| 24 | WEE1 | 1.66509821 |
| 25 | NTRK1 | 1.66060406 |
| 26 | PTK2B | 1.62837464 |
| 27 | BCKDK | 1.56374427 |
| 28 | PDGFRA | 1.55508925 |
| 29 | MYLK | 1.52803747 |
| 30 | CDK19 | 1.50055578 |
| 31 | ZAP70 | 1.41332814 |
| 32 | IKBKE | 1.30813215 |
| 33 | JAK3 | 1.26111598 |
| 34 | MET | 1.25440884 |
| 35 | ADRBK2 | 1.25064499 |
| 36 | RPS6KB2 | 1.24992753 |
| 37 | PRKG2 | 1.24951592 |
| 38 | TTN | 1.22683800 |
| 39 | MOS | 1.22395232 |
| 40 | MKNK1 | 1.22162464 |
| 41 | TBK1 | 1.17740810 |
| 42 | LATS2 | 1.12299335 |
| 43 | MAPKAPK3 | 1.11322967 |
| 44 | PKN2 | 1.09664893 |
| 45 | BRSK2 | 1.06177889 |
| 46 | MAP3K6 | 1.04878716 |
| 47 | MAPKAPK5 | 1.04564269 |
| 48 | DYRK3 | 1.02206331 |
| 49 | CDK8 | 1.01313778 |
| 50 | PIM2 | 0.99777621 |
| 51 | VRK1 | 0.99143737 |
| 52 | PAK4 | 0.97300948 |
| 53 | NLK | 0.96582208 |
| 54 | MAP3K13 | 0.94393100 |
| 55 | PIK3CG | 0.91773559 |
| 56 | TESK1 | 0.91425964 |
| 57 | CSK | 0.91178577 |
| 58 | FES | 0.89276492 |
| 59 | SYK | 0.87495292 |
| 60 | LRRK2 | 0.87258750 |
| 61 | RIPK1 | 0.87248813 |
| 62 | IRAK4 | 0.86646710 |
| 63 | DDR2 | 0.85611333 |
| 64 | LIMK1 | 0.83098928 |
| 65 | GRK1 | 0.82716580 |
| 66 | PASK | 0.82696920 |
| 67 | ROCK1 | 0.81177322 |
| 68 | ROCK2 | 0.80600707 |
| 69 | ERN1 | 0.79761183 |
| 70 | CCNB1 | 0.79417603 |
| 71 | PDGFRB | 0.77702507 |
| 72 | TYK2 | 0.77404340 |
| 73 | CAMKK2 | 0.75715223 |
| 74 | PAK2 | 0.75513282 |
| 75 | IKBKB | 0.73972333 |
| 76 | PIM1 | 0.71698956 |
| 77 | EPHB1 | 0.71426679 |
| 78 | MKNK2 | 0.71330392 |
| 79 | MAP2K6 | 0.70948358 |
| 80 | TAOK3 | 0.70834148 |
| 81 | LCK | 0.70325870 |
| 82 | LYN | 0.68687846 |
| 83 | RPS6KA4 | 0.68073915 |
| 84 | TXK | 0.67007284 |
| 85 | HIPK2 | 0.66574731 |
| 86 | PRKD3 | 0.63280872 |
| 87 | ERBB4 | 0.60816756 |
| 88 | CAMK1 | 0.58931030 |
| 89 | PLK2 | 0.58587038 |
| 90 | MAPK4 | 0.56839152 |
| 91 | GRK5 | 0.52736052 |
| 92 | FGFR3 | 0.52353451 |
| 93 | BMPR1B | 0.49763602 |
| 94 | MAPK7 | 0.48938798 |
| 95 | ABL2 | 0.48340073 |
| 96 | DAPK1 | 0.48323097 |
| 97 | STK10 | 0.46149450 |
| 98 | PINK1 | 0.44295084 |
| 99 | STK39 | 0.44290970 |
| 100 | CHUK | 0.43981278 |
| 101 | ARAF | 0.43740760 |
| 102 | PRKD1 | 0.43580233 |
| 103 | ILK | 0.42301661 |
| 104 | CAMK4 | 0.42284058 |
| 105 | CDK7 | 0.42036654 |
| 106 | CDK9 | 0.41830123 |
| 107 | OBSCN | 0.41595564 |
| 108 | MAP3K7 | 0.41521626 |
| 109 | CDK6 | 0.41437378 |
| 110 | MAPK12 | 0.41193741 |
| 111 | FGFR4 | 0.40858765 |
| 112 | PRKCE | 0.40437523 |
| 113 | TNK2 | 0.40432833 |
| 114 | BLK | 0.40269778 |
| 115 | HCK | 0.39928844 |
| 116 | DMPK | 0.39705448 |
| 117 | PRKAA2 | 0.39498423 |
| 118 | PAK6 | 0.39035588 |
| 119 | ITK | 0.38162256 |
| 120 | PDK2 | 0.37015283 |
| 121 | MAP2K1 | 0.35971559 |
| 122 | TRPM7 | 0.33533407 |
| 123 | NEK9 | 0.33268181 |
| 124 | STK38 | 0.32756545 |
| 125 | GSK3A | 0.32530174 |
| 126 | INSR | 0.31982345 |
| 127 | SRC | 0.31884806 |
| 128 | EGFR | 0.31596849 |
| 129 | JAK1 | 0.31124228 |
| 130 | IRAK3 | 0.29639985 |
| 131 | MAP3K11 | 0.28355873 |
| 132 | ERBB3 | 0.28326409 |
| 133 | RPS6KA6 | 0.27816005 |
| 134 | TSSK6 | 0.27654600 |
| 135 | CDK4 | 0.27451473 |
| 136 | KSR2 | 0.27409259 |
| 137 | MAP3K3 | 0.27068215 |
| 138 | YES1 | 0.26692403 |
| 139 | BRD4 | 0.26535608 |
| 140 | EIF2AK3 | 0.25686312 |
| 141 | IGF1R | 0.25682480 |
| 142 | MAPK11 | 0.24606057 |
| 143 | JAK2 | 0.24540470 |
| 144 | DAPK3 | 0.23266359 |
| 145 | AKT2 | 0.22863970 |
| 146 | RPS6KA2 | 0.21730349 |
| 147 | MAPK3 | 0.21575144 |
| 148 | ADRBK1 | 0.20642510 |
| 149 | PTK6 | 0.18617933 |
| 150 | EPHA2 | 0.15764986 |
| 151 | PAK3 | 0.15608549 |
| 152 | CDC42BPA | 0.14688462 |
| 153 | KSR1 | 0.13011133 |
| 154 | LATS1 | 0.12969296 |
| 155 | EPHA3 | 0.12337768 |
| 156 | FGFR1 | 0.11765377 |
| 157 | PRKG1 | 0.09698375 |
| 158 | STK38L | 0.08823549 |
| 159 | PRKD2 | 0.08071549 |
| 160 | SGK3 | 0.08028584 |
| 161 | CAMK2A | 0.07943573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.47742878 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.19404619 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.13452098 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.07914491 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.52182327 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.46650136 |
| 7 | Adherens junction_Homo sapiens_hsa04520 | 2.45494582 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.43210996 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.23857295 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.23338574 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.22271595 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.18427452 |
| 13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.16879633 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10545107 |
| 15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.09758815 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.05813618 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.03769506 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.02254395 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.97206802 |
| 20 | Platelet activation_Homo sapiens_hsa04611 | 1.95817198 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82390917 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.79579675 |
| 23 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.77829675 |
| 24 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.77213972 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66662168 |
| 26 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64207134 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62532590 |
| 28 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.60961993 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.59955585 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57635674 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.54087942 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53440389 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50910171 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48801435 |
| 35 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.47356232 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45010395 |
| 37 | Tight junction_Homo sapiens_hsa04530 | 1.43869041 |
| 38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.42414852 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.41505849 |
| 40 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.40253803 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39897978 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38360217 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.37385714 |
| 44 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.33776519 |
| 45 | Spliceosome_Homo sapiens_hsa03040 | 1.27110654 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.26895973 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.25413395 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.24872792 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.23178774 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21992313 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.21580748 |
| 52 | Malaria_Homo sapiens_hsa05144 | 1.21288012 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 1.19621374 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.18315498 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17702499 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14590912 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 1.14147899 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13577323 |
| 59 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.07032567 |
| 60 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.04676466 |
| 61 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.02984799 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02950225 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02770007 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01594223 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01371818 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.99500295 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99296291 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.99083586 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98795618 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98416764 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.97265983 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.95313415 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94325416 |
| 74 | Legionellosis_Homo sapiens_hsa05134 | 0.92727800 |
| 75 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92630438 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92417515 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90046661 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89828808 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88221476 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87891094 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85832973 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84256218 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.83907930 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83799184 |
| 85 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83455464 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.81902654 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80220062 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.79719389 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.78221004 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78034953 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.77965325 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77932489 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77552473 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75972292 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74824058 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.73267698 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71173943 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70653920 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69622893 |
| 100 | Melanogenesis_Homo sapiens_hsa04916 | 0.69321178 |
| 101 | Cell cycle_Homo sapiens_hsa04110 | 0.68042036 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66170951 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66050385 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65315112 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64720386 |
| 106 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63639353 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63093601 |
| 108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61489772 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59262257 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58945427 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57815016 |
| 112 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56259241 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | 0.55288775 |
| 114 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53490007 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.52920148 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52640831 |
| 117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.50794195 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50507202 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50409546 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50340481 |
| 121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49339525 |
| 122 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48255938 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48167780 |
| 124 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47400174 |
| 125 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47263624 |
| 126 | Asthma_Homo sapiens_hsa05310 | 0.47134653 |
| 127 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47113187 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46959245 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.46496229 |
| 130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45720943 |
| 131 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.45029483 |
| 132 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44728657 |
| 133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44375176 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44008337 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43911310 |
| 136 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43249089 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.43128726 |
| 138 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42985877 |
| 139 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42961794 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41351073 |
| 141 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.41023852 |
| 142 | Melanoma_Homo sapiens_hsa05218 | 0.39728367 |
| 143 | Focal adhesion_Homo sapiens_hsa04510 | 0.39684916 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39191503 |
| 145 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38878260 |
| 146 | Insulin resistance_Homo sapiens_hsa04931 | 0.38672675 |
| 147 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38395249 |
| 148 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38316743 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37802572 |
| 150 | Apoptosis_Homo sapiens_hsa04210 | 0.37397857 |
| 151 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37204669 |
| 152 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36505646 |
| 153 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35166533 |
| 154 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35059587 |
| 155 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34944503 |
| 156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33514758 |
| 157 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33382376 |
| 158 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32891357 |
| 159 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32156389 |
| 160 | Phagosome_Homo sapiens_hsa04145 | 0.31975854 |
| 161 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31314024 |
| 162 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30910476 |
| 163 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30683426 |
| 164 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30509113 |
| 165 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30502478 |
| 166 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29972395 |
| 167 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29971797 |
| 168 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28953512 |
| 169 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27732049 |
| 170 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27549846 |

